[1]
“Efficacy of Deucravacitinib in Plaque Psoriasis Across a Range of Body Surface Area Involvement: Post hoc Analysis of the Randomized, Double-Blinded, Placebo-Controlled, Phase 3b/4 PSORIATYK SCALP Trial”, J of Skin, vol. 8, no. 6, p. s429, Nov. 2024, doi: 10.25251/skin.8.supp.429.